Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Clinical Trial

Comparative Study

Multicenter Study

Review

Clinical Trial, Phase II

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2015

2012

2011

2010

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Eptifibatide""[mesh_terms]

35 Results

Searching titles within these results

Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention.

Michele Schiariti, Angela Saladini, Domenico Cuturello, Bindo Missiroli, Paolo Emilio Puddu

Journal of cardiovascular medicine (Hagerstown, Md.) 2011;12(1):29-36

Full Text

Abstract

Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.

A M Lincoff, R A Harrington, R M Califf, J S Hochman, A D Guerci, E M Ohman, C J Pepine, S L Kopecky, N S Kleiman, C M Pacchiana, L G Berdan, M M Kitt, M L Simoons, E J Topol

Circulation 2000;102(10):1093-100

Full Text

Abstract

Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Ian C Gilchrist

Clinical pharmacokinetics 2004;42(8):703-20

Full Text

Abstract

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

J C Blankenship, G Tasissa, J C O'Shea, E A Iliadis, F A Bachour, D J Cohen, H K Lui, T Mann, E Cohen, J E Tcheng

Journal of the American College of Cardiology 2001;38(3):653-8

Free Full Text

Abstract

New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.

R A O'Rourke, J S Hochman, M C Cohen, C L Lucore, J J Popma, C P Cannon

Archives of internal medicine 2001;161(5):674-82

Full Text

Abstract

Management of intermediate coronary syndrome: role of conservative treatment, glycoprotein IIb/IIIa receptor inhibitors, and direct intervention.

G C Robertson

The American journal of cardiology 2000;85(5A):21B-26B

Free Full Text

Abstract

Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study).

Jorge F Saucedo, Luis Garza, David C Wolford, Stephen L Cook, Kodangudi B Ramanathan, Zakaria Matin, Frank A McGrew, Mary V Jacoski, Lisa K Jennings

The American journal of cardiology 2004;93(10):1279-82

Full Text

Abstract

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.

I C Gilchrist, J C O'Shea, T Kosoglou, L K Jennings, T J Lorenz, M M Kitt, N S Kleiman, D Talley, F Aguirre, C Davidson, J Runyon, J E Tcheng

Circulation 2001;104(4):406-11

Full Text

Abstract

Platelet glycoprotein receptor site blockade in coronary artery disease.

D R Holmes

Current cardiology reports 2000;2(1):69-73

Full Text

Abstract

Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.

Ravi R Bajaj, Atif Mohammad, Tony Hong, Affan Irfan, Waseem Sharieff, Alan Bagnall, Jo-Ann Christie, Michael J B Kutryk, Robert J Chisholm, Asim N Cheema

The Journal of invasive cardiology 2010;22(8):347-52

Full Text

Abstract

A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.

Giuseppe G L Biondi-Zoccai, Marco Valgimigli, Imad Sheiban, Massimo Margheri, Antonio Marzocchi, Francesco Prati, Massimo Vischi, Corrado Lettieri, Roberto Violini, Gennaro Sardella, Amerigo Stabile, Fabrizio Clementi, Francesco Romeo, Antonio Colombo, Giuseppe Sangiorgi

Journal of cardiovascular medicine (Hagerstown, Md.) 2008;9(9):957-62

Full Text

Abstract

Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.

C Michael Gibson, Jacqueline Buros, Lauren N Ciaglo, Matthew C Southard, Shaun Takao, Caitlin Harrigan, Jason Filopei, Michelle Lew, Susan J Marble, Sabina A Murphy, Mauricio G Cohen

The American journal of cardiology 2007;100(1):13-7

Full Text

Abstract

Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial.

Bernd Jilma, Ulla Derhaschnig, Christine Pachinger

American heart journal 2004;147(4):E17

Full Text

Abstract

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

B E Tardiff, L K Jennings, R A Harrington, D Gretler, R F Potthoff, D A Vorchheimer, P R Eisenberg, A M Lincoff, M Labinaz, D M Joseph, M F McDougal, N S Kleiman

Circulation 2001;104(4):399-405

Full Text

Abstract

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.

C Michael Gibson, Sabina A Murphy, Susan J Marble, David J Cohen, Eric A Cohen, Henry K Lui, Jeffrey Young, Michael M Kitt, Todd J Lorenz, James E Tcheng

American heart journal 2002;143(1):106-10

Full Text

Abstract

Results: 1 – 15 / 35

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Eptifibatide""[mesh_terms]

Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention.

Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.

Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.

Management of intermediate coronary syndrome: role of conservative treatment, glycoprotein IIb/IIIa receptor inhibitors, and direct intervention.

Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study).

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.

Platelet glycoprotein receptor site blockade in coronary artery disease.

Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.

A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.

Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.

Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial.

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.

Results for
""Eptifibatide""[mesh_terms]